MarketPulse

dialysis

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

R1 Therapeutics Launches With $77.5M Series A to Develop First-in-Class Kidney Disease Treatment

R1 Therapeutics raised $77.5M in oversubscribed Series A funding to advance AP306, a first-in-class treatment for hyperphosphatemia in chronic kidney disease patients.
DVAclinical developmentdialysis
GlobeNewswire Inc.GlobeNewswire Inc.··American Kidney Fund

American Kidney Fund Launches National Awareness Campaign Amid Rising Disease Prevalence

American Kidney Fund launches "Kidneys Count" campaign March 1, 2026, promoting early detection and prevention of kidney disease affecting 1 in 7 American adults.
AMGNARGXNVSTVTXkidney diseaseearly detection